ArticleAlzheimer's research & therapy2020

Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.

Carmen Hierro-Bujalance et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.